¾È¾Ï 01-07
[¾È¾Ï] ¾È±âÈÆ ±³¼öÆÀ, Á¶»êÀ» ȹ±âÀûÀ¸·Î ÁÙÀÏ ¼ö ÀÖ´Â ÀüÀÚ¾à °³¹ß
¾È¾Ï 01-05
[¾È¾Ï] ±è½Å°ï ±³¼ö, ÀÌÀç¸í ±³¼ö, Á¦20ȸ Çѹ̼öÇʹ®Çлó ¼ö»ó
¾È¾Ï 12-30
[¾È¾Ï] À¯¿µ ±³¼öÆÀ, °¡Á¤ ³» °õÆÎÀÌ¿Í ±âµµ°ú¹Î¼º »ó°ü°ü°è ¹àÇô
[¾È¾Ï] ÆÛÁñ¿¡À̾ÆÀÌ¿Í Â÷¼¼´ë VOICE EMR °øµ¿°³¹ß MOUü°á
¾È¾Ï 12-24
[¾È¾Ï] ÀÌ»óÇÐ ±³¼ö, ±³À°ºÎ Çмú¡¤¿¬±¸Áö¿ø»ç¾÷ ¿ì¼ö¼º°ú ¼±Á¤
¾È¾Ï 12-21
[¾È¾Ï] ¹Ú¼º¹Ì ±³¼öÆÀ,ƯÁ¤Áúȯ °¡Áø ÀþÀº ȯÀÚ°¡ COVID-19°¨¿°¿¡ ´õ¿í Ãë¾àÇÔ ±Ô¸í
¾È¾Ï 12-18
[¾È¾Ï] ÀÌÀç¸í ±³¼ö, º¸°Çº¹ÁöºÎÀå°üǥâ ¼ö»ó
¾È¾Ï 12-14
[¾È¾Ï] ¹«¼öÇ÷¼¾ÅÍ, Çѱ¹ÀÇ·áÁúÇâ»óÇÐȸ ÃÖ¿ì¼ö ±¸¿¬»ó ¼ö»ó
[¾È¾Ï] À̼±¿í ±³¼ö, ´ëÇÑÆòÇüÀÇÇÐȸ ÀþÀº¿¬±¸ÀÚ»ó ¼ö»ó
¾È¾Ï 12-11
[¾È¾Ï] ±¹°¡°í°´¸¸Á·µµ(NCSI) TOP 3 Äè°Å
ÇØ´ç ½ºÅ©¸³Æ®°¡ Á¤»óÀûÀ¸·Î ÀÛµ¿ÇÏÁö ¾Ê½À´Ï´Ù. ºÒÆíÀ» µå·Á¼ Á˼ÛÇÕ´Ï´Ù.